NASDAQ:CERU
Delisted

Cerulean Pharma Fund Signals

etoro logo Buy CERU
*Your capital is at risk
$0.660
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Below are some of the latest signals issued for Cerulean Pharma Inc.

General

Signal Type Signal Value Data
Score 0.000 64 days ( 14.29 %
Last Price $0.660 0 %
Performance History
7 Days
$0.660 $0.660
0%
30 Days
$0.660 $0.660
0%
12 Mos
$0.84 $0.660
-21.43%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 45.27
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.660 - $0.660
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 15, 2018 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Dec 01, 2017 - 30 days
Short/Long MA 3 mos Buy Medium Dec 01, 2017 - 30 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos -19.80 % Very High Width: 436.26 %
Pred. range - 12 mos N/A - $2.24 High -100.00 % - 238.80 %
Short MA 12 mos Buy Very High Jul 31, 2017 - 51 days
Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Buy Low Jul 18, 2017 - 60 days
RSI Long Pivot Signal Buy Low Aug 10, 2017 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CERULEAN PHARMA INC.
Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company’s lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE